Averion, a leading Contract Research Organization with more than 20 years of experience managing clinical trials, chose Protocol Manager, Winchester’s clinical trials management system (CTMS), and the paraFILE document management system to increase the efficiency of its project management services.

"Protocol Manager will allow us to improve team communications, integrate our operations and manage trial data more efficiently for our clients." said Bonnie Neuhardt, Averion’s Chief Information Officer. “This investment reinforces Averion’s commitment to providing our clients with decision making and oversight tools for hastening product development times”.

"We are committed to our clients and employees to offer the latest technology innovations to improve the product development process for our clients." commented, Dr. Philip Lavin, Averion President and CEO.

Protocol Manager and paraFILE are proprietary software systems developed and supported by Winchester. Protocol Manager increases the efficiency of communications between parties involved in clinical trials by allowing access to global clinical trial data electronically, eliminating the need to transcribe, mail and fax traditional paper forms. paraFILE helps develop and publish company working documents -- SOPs, site-essential documents, contracts, and other regulatory documents in a compliant, collaborative environment.

“We are pleased to be a part of the product development process,” said Michael Regentz, Winchester's Managing Director. “Winchester has the business knowledge and is committed to insure success of this effort to streamline clinical trials management.”